Trials / Completed
CompletedNCT01956110
Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,329 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This trial investigates the effects of FE 999049 compared to GONAL-F.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Follitropin Delta (FE 999049) | |
| DRUG | Follitropin Alfa (GONAL-F) |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-05-01
- Completion
- 2017-01-03
- First posted
- 2013-10-08
- Last updated
- 2022-01-13
- Results posted
- 2018-09-25
Locations
13 sites across 11 countries: Belgium, Brazil, Canada, Czechia, Denmark, France, Italy, Poland, Russia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01956110. Inclusion in this directory is not an endorsement.